Clinical trial
Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa…
NCT00169221 · Groupe Oncologie Radiotherapie Tete et Cou, Other · Terminated
Key facts
| NCT number | NCT00169221 |
|---|---|
| Title | Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas |
| Official title | CARISSA Trial - Multicenter Randomized Phase II Trial Comparing Post-operative Radiotherapy and Cisplatin Alone or in Combination With the EGFR Inhibitor ZD 1839 (Iressa) in Upper Aerodigestive Tract Carcinomas |
| Lead sponsor | Groupe Oncologie Radiotherapie Tete et Cou, Other |
| Collaborators | AstraZeneca Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Iressa (Gefitinib), chemoradiotherapy with cisplatin |
| Enrollment | 54 |
| Start date | Sep 1, 2005 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2011 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 15, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: